Animal models for acquired heterotopic ossification.

Area of Science:

• Musculoskeletal Disorders
• Pathophysiology
• Biochemistry

Background:

• Heterotopic ossification (HO) involves ectopic bone formation in soft tissues, causing significant mobility impairment.
• HO can be acquired (e.g., post-surgery, trauma) or hereditary, affecting joints and the axial skeleton.
• Current treatments lack complete efficacy, necessitating further research into pathophysiology and prophylaxis.

Purpose of the Study:

• To review the history and features of animal models for acquired heterotopic ossification (HO).
• To highlight insights gained from studying these animal models.
• To emphasize the importance of selecting appropriate models for HO research.

Main Methods:

• Review of existing literature on animal models of acquired HO.
• Analysis of the history and characteristics of six commonly used animal models.
• Highlighting key biochemical and pathophysiological features relevant to HO.

Main Results:

• Six distinct animal models are regularly employed for studying acquired HO.
• Each model may only represent specific aspects of the disease.
• Clinical studies show indomethacin, celecoxib, and radiation therapy can reduce, but not always prevent, HO.

Conclusions:

• Animal models are essential for advancing the understanding and treatment of acquired HO.
• Careful selection of animal models is critical for relevant research findings.
• Despite some effective interventions, reliable prophylaxis and treatment for HO remain elusive.